American Oncology Network, Inc.

American Oncology Network, Inc. (Nasdaq: AONC) is a value-based, community oncology and hematology services company that entered the public markets through a business combination with GX Acquisition Corp. II, a blank-check vehicle sponsored by GX Sponsor II LLC that completed its IPO in 2021. The company operates in the healthcare sector, delivering physician-led cancer care across a multi-state network of clinics in the United States. In October 2023, AONC filed an S-1 registration statement, a standard post-merger step to register shares and satisfy public reporting obligations following the completed de-SPAC transaction. Visit SpacDesk and sign up for full filing data, sponsor details, and real-time deal tracking on AONC and the broader SPAC universe.